Pharmaceutical Quality (Industry)
1.0.0 - STU1 International flag

This page is part of the Pharmaceutical Quality (Industry) (v1.0.0: STU1) based on FHIR (HL7® FHIR® Standard) v5.0.0. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

Stability Study

Details about a stability study including stability study design (tests and acceptance criteria), drug substance or drug product batches involved, test results, and conclusion.

Product

Resources

MedicinalProductDefinitionThe drug product (Stelbat tablets, 20mg)
IngredientThe active ingredient (stelbatalol) or the ingredients that make up the drug product
SubstanceDefinitionChemical or biological details about substance(s) associated with the ingredient
MedicationDescribes the batches that underwent stability testing
PlanDefinitionDescribes the stability study protocol
ActivityDefinitionUsed to group tests such as by timings
ObservationDefinitionEach individual test and acceptance criteria; also used to group closely related tests
Specimen(not illustrated above) Identifying information about an individual specimen (an instance)
ObservationThe results of a specific test mentioned in the ObservationDefinition
DiagnosticReportContains all results as a group and captures conclusions
Organization(not illustrated above) The company/site that performed the testing or manufacturing

Examples

CTD section synthetic source data samples (PDF):

XML and JSON examples of synthetic quality data:

HTML presentation example of synthetic quality data:

  • Drug Product Stability - Note that HTML examples represent ways to create human-readable output using structured quality data (see section 1.2 Scope).

Substance

Resources

SubstanceDefinitionThe substance being tested
SubstanceIdentifying information about an actual batch of substance being tested (an instance)
PlanDefinitionDescribes the stability study protocol
ActivityDefinitionUsed to group tests such as by timings
ObservationDefinitionEach individual test and acceptance criteria; also used to group closely related tests
SpecificationDefinitionDescribes the storage conditions and duration for each test
Specimen(not illustrated above) Identifying information about an individual specimen (an instance)
ObservationThe results of a specific test mentioned in the ObservationDefinition
DiagnosticReportContains all results as a group and captures conclusions
Organization(not illustrated above) The company/site that performed the testing or manufacturing
SubstanceIdentifying information about an actual batch of substance (an instance)

Examples

CTD section synthetic source data samples (PDF):

XML and JSON examples of synthetic quality data:

HTML presentation example of synthetic quality data:

  • Drug Substance Stability - Note that HTML examples represent ways to create human-readable output using structured quality data (see section 1.2 Scope).

Profiles

See Artifacts Index: Domain Bundle Profiles